|
|
Volumn 328, Issue 7432, 2004, Pages 156-
|
|
Glaucoma—2: Treatment
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBONATE DEHYDRATASE INHIBITOR;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
PROSTAGLANDIN DERIVATIVE;
NEUROPROTECTIVE AGENT;
PROSTAGLANDIN;
ARGON LASER;
BETA ADRENERGIC RECEPTOR BLOCKING;
CLINICAL FEATURE;
DIODE LASER;
DRUG ABSORPTION;
DRUG FORMULATION;
DRUG HYPERSENSITIVITY;
DRUG WITHDRAWAL;
ELECTROLYTE DISTURBANCE;
EYE SYNECHIA;
EYELASH;
HUMAN;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
IRIDECTOMY;
LASER SURGERY;
LASSITUDE;
NAUSEA;
OPEN ANGLE GLAUCOMA;
PARESTHESIA;
POSTOPERATIVE COMPLICATION;
PRIMARY GLAUCOMA;
PRIORITY JOURNAL;
RETINA DETACHMENT;
REVIEW;
SIDE EFFECT;
SURGICAL DRAINAGE;
TRABECULOPLASTY;
TREATMENT INDICATION;
GLAUCOMA;
METHODOLOGY;
WOUND DRAINAGE;
ADRENERGIC BETA-ANTAGONISTS;
CARBONIC ANHYDRASE INHIBITORS;
DRAINAGE;
GLAUCOMA;
HUMANS;
IRIDECTOMY;
LASER SURGERY;
NEUROPROTECTIVE AGENTS;
PARASYMPATHOMIMETICS;
PROSTAGLANDINS;
|
|
EID: 1642463329
PISSN: 09598138
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.328.7432.156 Document Type: Article |
|
Times cited : (32)
|
|
References (0)
|